Faculty

David Armstrong

DPM MD PhD
Professor
University of Southern California School of Medicine

David G. Armstrong is Distinguished Professor of Surgery and Neurological Surgery with Tenure at the University of Southern California. He has authored over 780 peer-reviewed research papers and 120 books or book chapters. He co-founded the Southwestern Academic Limb Salvage Alliance (SALSA) and leads USC's NSF-funded Center to Stream Healthcare in Place (C2SHiP). At C2SHiP, Dr. Armstrong finds himself at the nexus of consumer electronics and medical devices, exploring their integration for enhanced patient care.

Dr. Armstrong's has received numerous awards by national and international institutions including the Georgetown Distinguished Award for Diabetic Limb Salvage and the 2023 ISDF’s Karel Bakker Award. As the first podiatric surgeon to be named fellow of the Royal College of Surgeons, Glasgow, and the Founding President of the American Limb Preservation Society, he has made significant strides in his field. Dr. Armstrong is committed to ending preventable amputation within the next generation, a goal that he advances through fostering innovative interdisciplinary research, clinical practice, and advocacy.

2026 Sessions

Accredited Industry-Supported Symposium Lunch: Peripheral Arterial Diseases and Plasmid DNA Therapy: From Current Standards of Care to Emerging Clinical Innovation

Supported by an educational grant from PERI and AnGes, Inc..<br><br>

This session will award 1.00 pharmacotherapeutic contact hour.<br><br>

<b>Learning Objectives:</b><br>
1. Review the current standard of care and treatment approaches for patients with arterial ulcers associated with peripheral arterial disease (PAD).<br>
2. Examine the scientific rationale and clinical development of plasmid DNA therapy, including key findings from two decades of clinical investigation.<br>
3. Analyze the design, methodology, and clinical outcomes of the LEGEND-1 registrational trial evaluating investigational gene therapy in patients with moderate peripheral arterial disease and ulcers.<br>
4. Evaluate wound validation methodologies and review clinical case data from the pivotal trial to better understand patient selection, wound assessment, and treatment outcomes.

ISS Speaker

Friday, October 16 12:15–1:45 PM
Room Octavius 15
Industry-Supported Symposia
Faculty

David Armstrong

DPM MD PhD
Professor
University of Southern California School of Medicine

David G. Armstrong is Distinguished Professor of Surgery and Neurological Surgery with Tenure at the University of Southern California. He has authored over 780 peer-reviewed research papers and 120 books or book chapters. He co-founded the Southwestern Academic Limb Salvage Alliance (SALSA) and leads USC's NSF-funded Center to Stream Healthcare in Place (C2SHiP). At C2SHiP, Dr. Armstrong finds himself at the nexus of consumer electronics and medical devices, exploring their integration for enhanced patient care.

Dr. Armstrong's has received numerous awards by national and international institutions including the Georgetown Distinguished Award for Diabetic Limb Salvage and the 2023 ISDF’s Karel Bakker Award. As the first podiatric surgeon to be named fellow of the Royal College of Surgeons, Glasgow, and the Founding President of the American Limb Preservation Society, he has made significant strides in his field. Dr. Armstrong is committed to ending preventable amputation within the next generation, a goal that he advances through fostering innovative interdisciplinary research, clinical practice, and advocacy.

Faculty

John Lantis

MD
Professor of Surgery
Icahn School of Medicine and Mount Sinai West Hospita

John C. Lantis II, MD, is currently the site Chief and Professor of Surgery at Mount Sinai West Hospital, and the Icahn School of Medicine; in mid-town Manhattan where he practices as a senior vascular surgeon. On January 1, 2024; he was named the Director of advanced wound care; Department of surgery; Mount Sinai healthcare system.
In 2023 he became the Editor in Chief of the journal WOUNDS; a Clinical Compendium. He is the past president of the New York Vascular Surgery Society, a founding member of the American Board of Wound Medicine and Surgery, and the Vascular Study Group of New York.

Faculty

Dennis Orgill

MD, PhD
Medical Director, Wound Care Center
Brigham and Women's Hospital

Dr. Orgill is a reconstructive plastic surgeon at Brigham and Women’s Hospital (BWH) in Boston who specializes in complex adult reconstructive surgery. He is the Director of the Wound Care Clinic at BWH and Professor of Surgery at Harvard Medical School. He has a PhD from MIT in Medical Engineering. He is a Plastic Surgeon at Brigham and Women's Hospital and Focus his clinical work on adult reconstructive surgery. His research is focused on working to develop better technologies to treat wounds including work with artificial skin, micromechanical forces, platelets and stem cells, and combining biologics, scaffolds and mechanical forces to improve wound healing and tissue engineering constructs. He has consulted for several medical device and start-up companies and is the inventor on several patents.

Faculty

Richard Powell

MD
Faculty

Charles Zelen

DPM
President and Medical Director
Professional Education and Research Institute

Charles M Zelen DPM FACFAS earned his Bachelor’s in Psychobiology from UC Riverside and he attended the California College of Podiatric Medicine where he received his doctorate of podiatric medicine and graduated as Valedictorian. He completed his residency at the INVOVA Fairfax Hospital and Georgetown University , where he was trained in foot and ankle surgery and diabetic limb salvage. Dr. Zelen has been in practice in Roanoke, VA for 26 years and serves as Foot and Ankle Section Chief at HCA Lewis Gale Hospital in the Department of Orthopedics. Dr. Zelen is President of the Professional Education and Research Institute , a lower extremity CRO that has been conducting foot and ankle clinical trials since 2005. Dr. Zelen is well published in the podiatric, orthopedic and plastic surgery literature and is considered an expert in limb slavage, wound care and clinical trials involving human tissue grafts.

Accredited Industry-Supported Symposia: A New Era in Diabetic Foot Management: The Science, Evidence, and Clinical Application of OFM-Hyaluronic Acid Technology

HMP Education has designated an unrestricted grant from Aroa Biosurgery for this session.<br><br>

<b>Learning objectives:</b><br>
1. Review current evidence-based management strategies for complex diabetic foot ulcers and discuss evolving challenges and opportunities to improve patient outcomes.<br>
2. Explain the complementary mechanisms of action of ovine forestomach matrix (OFM) and hyaluronic acid (HA), including their roles in modulating inflammation, supporting tissue regeneration, and promoting healing in diabetic foot ulcers (DFUs).<br>
3. Evaluate the current clinical evidence supporting OFM-HA technology for lower extremity reconstruction and diabetic foot ulcer management, including findings from randomized controlled trials.<br>
4. Apply evidence-based strategies for incorporating OFM-HA technology into individualized treatment plans for patients with diabetic foot ulcers through case-based discussions.<br>
5. Integrate clinical, operational, and reimbursement considerations into the adoption of OFM-HA technology.

ISS Speaker

Friday, October 16 4:30–5:30 PM
Room Octavius 7
Industry-Supported Symposia
Faculty

David Armstrong

DPM MD PhD
Professor
University of Southern California School of Medicine

David G. Armstrong is Distinguished Professor of Surgery and Neurological Surgery with Tenure at the University of Southern California. He has authored over 780 peer-reviewed research papers and 120 books or book chapters. He co-founded the Southwestern Academic Limb Salvage Alliance (SALSA) and leads USC's NSF-funded Center to Stream Healthcare in Place (C2SHiP). At C2SHiP, Dr. Armstrong finds himself at the nexus of consumer electronics and medical devices, exploring their integration for enhanced patient care.

Dr. Armstrong's has received numerous awards by national and international institutions including the Georgetown Distinguished Award for Diabetic Limb Salvage and the 2023 ISDF’s Karel Bakker Award. As the first podiatric surgeon to be named fellow of the Royal College of Surgeons, Glasgow, and the Founding President of the American Limb Preservation Society, he has made significant strides in his field. Dr. Armstrong is committed to ending preventable amputation within the next generation, a goal that he advances through fostering innovative interdisciplinary research, clinical practice, and advocacy.

Faculty

Michael Desvigne

MD, FACS, CWS, FACCWS, MAPWCA
Plastic surgeon
Abrazo Arrowhead Hospital & Wound Center

Dr. Michael N. Desvigne is a true plastic and reconstructive surgeon who has chosen to dedicate his expertise to reconstructive surgery, specifically wound reconstruction. Dr, Desvigne believes performing reconstructive surgery has made him a better wound healing clinician and managing complex wounds has made him a better reconstructive surgeon. Dr. Desvigne brings a wealth of experience from a variety of disciplines. He is board certified in plastic surgery, general surgery, wound care and hyperbaric medicine. With this quadruple certification he approaches each wound problem with a staircase approach including surgical and nonsurgical solutions.

Dr. Desvigne is a fellow of the American College of Surgeons (ACS). He is a member of the American Society of Plastic Surgery (ASPS), the American Society of Aesthetic Plastic Surgery (ASAPS) and the Arizona Society of Plastic Surgeons. He is also a member of the American Academy of Wound Specialists, Wound Healing Society and the Undersea and Hyperbaric Medical Society. He is a world-renowned lecturer and consultant in wound healing technologies. He has created multiple programs for inpatient and outpatient centers of excellence in wound care, with a focus on the continuum of care.

Faculty

Ira Herman

PhD
Professor
Tufts University School of Medicine

Brief Biosketch:
Ira M. Herman, Ph.D.
Professor and Director, Emeritus
Center for Innovations in Wound Healing Research
Tufts University School of Medicine
150 Harrison Avenue
Boston, MA 02111

Ira M. Herman, Ph.D.
Chief Science Officer
Tissue Health Plus
Email: ira@tissuehealthplus.com
Mobile: 617.388.6124
LinkedIn: https://www.linkedin.com/in/ira-herman-14457517/

For the entirety of his discovery- and innovation-based career, and since his days in training at Tulane University, Harvard Medical School and The Johns Hopkins University School of Medicine, and to the present as Chief Science Officer, Tissue Health Plus, Dr Herman has been devoted to understanding the basic mechanisms that control the fundamental properties of life, including motility, repair and regeneration at the molecular, cellular and tissue levels. As a global thought leader, Dr. Herman and his colleagues have made several seminal contributions to our understanding the molecular mechanisms that control post-injury responses, while unveiling those central factors, signaling networks and supramolecular complexes responsible for regulating host reparative responses. These fundamental insights have given way to innovative strategies and inventions aimed at controlling wound healing, while converting non-healing wounds into those capable of closure. As a lead innovator and key opinion leader, Dr. Herman has chaired and served on innumerable grant review panels and editorial boards for high-impact
journals. He has received numerous awards, published 100s of peer-reviewed scientific publications and is named inventor on many US and international patents describing advanced diagnostics and therapeutics for next generation, precision health care and a member of the National Academy of Inventors.

Faculty

George Koullias

MD, PhD, FSVS, RPVI
Associate Professor of Surgery Division of Vascular & Endovascular Surgery
Stony Brook University Hospital & Stony Brook Southampton Hospital
Back to top